Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H26N2O |
| Molecular Weight | 370.4867 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N#CC1=CC2=C(OC3=CC=CC=C3C4=C2CCN(CC5CCCC5)CC4)C=C1
InChI
InChIKey=MUAHMQUPOQGKOQ-UHFFFAOYSA-N
InChI=1S/C25H26N2O/c26-16-19-9-10-25-23(15-19)21-12-14-27(17-18-5-1-2-6-18)13-11-20(21)22-7-3-4-8-24(22)28-25/h3-4,7-10,15,18H,1-2,5-6,11-14,17H2
| Molecular Formula | C25H26N2O |
| Molecular Weight | 370.4867 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Savoxepine (also known as cipazoxapine), a tetracyclic compound, possesses a potent neuroleptic-like effects. This compound acts via dopamine D(2)-receptor blockade. Savoxepine was studied in phase II clinical trials in Europe for the treatment of patients with psychotic disorders; however, these studied were discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Direct microtitre plate radioimmunoassay of savoxepine in unextracted plasma. | 1996-02 |
|
| Savoxepine fails to selectively influence glucose metabolism in the rat limbic system. | 1994-03 |
|
| Savoxepine: striatal dopamine-D2 receptor occupancy in human volunteers measured using positron emission tomography (PET). | 1993 |
|
| Neuroleptic profile of cipazoxapine (Savoxepine), a new tetracyclic dopamine antagonist: clinical validation of the hippocampus versus striatum ratio model of dopamine receptors in animals. A preliminary report. | 1987-05 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2565583
In an open pilot-study 18 patients suffering from acute schizophrenic psychoses or paranoid syndromes were treated with savoxepine in an individually adapted dose range from 0.50 to 10 mg per day
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:30:27 GMT 2025
by
admin
on
Mon Mar 31 19:30:27 GMT 2025
|
| Record UNII |
13343J27CI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66883
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
13343J27CI
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY | |||
|
C152310
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY | |||
|
54359
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY | |||
|
SUB10461MIG
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY | |||
|
100000084101
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY | |||
|
DTXSID20229594
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105557
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY | |||
|
5907
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY | |||
|
79262-46-7
Created by
admin on Mon Mar 31 19:30:27 GMT 2025 , Edited by admin on Mon Mar 31 19:30:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |